Newer Form of Heparin Better at Preventing Clots After Stroke

In this article, two different forms of anticoagulant went head-to-head in a test to see which one proved to be better for patients after a stroke. The patients that took heparin received twice a day dosages where as the other patients received once a day dosages of enoxaparin (a new form of heparin). The interesting thing is that the new drug appeared to work better. I am personally skeptical about this particular test because it was sponsored by the makers of enoxaparin.

The true test though will not be in the performance of this new data, but how the writers of the guidelines to stroke management do with this particular data. Will they accept it and bring it in, or ignore it in general? I personally think that if these data results are indeed correct and true that the writers should include this data in their writings.

http://health.msn.com/centers/highbloodpressure/articlepage.aspx?cp-documentid=100161211